Cargando…
Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
BACKGROUND: Genetic alterations, including the overexpression of epidermal growth factor receptor (EGFR), play a crucial role in ovarian carcinogenesis. To date, EGFR targeting has shown limited antitumor effects in ovarian cancer when administered as monotherapy. We previously identified platelet-a...
Autores principales: | Yu, Yi, Zhang, Mingxing, Zhang, Xiaoyan, Cai, Qingqing, Hong, Shanshan, Jiang, Wei, Xu, Congjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028110/ https://www.ncbi.nlm.nih.gov/pubmed/24886678 http://dx.doi.org/10.1186/1756-8722-7-39 |
Ejemplares similares
-
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014) -
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A(2) in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014) -
Interactions between the receptors for platelet-derived growth factor and epidermal growth factor
Publicado: (1983) -
Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004) -
Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)